Literature DB >> 20167973

Prevalence of metabolic syndrome in psychiatric inpatients in a tertiary care centre in north India.

Surendra K Mattoo1, Shubh Mohan Singh.   

Abstract

BACKGROUND &
OBJECTIVES: Metabolic syndrome (MS) is associated with major mental illnesses. It is a major predictor of mortality and morbidity. This research was undertaken to study the prevalence and correlates of MS in psychiatric inpatients in a tertiary care hospital in north India.
METHODS: Consecutive adult patients with a primary psychiatric disorder admitted to the psychiatric ward during the study period (July-December 2007) were evaluated for prevalence of MS as per the criteria of the International Diabetes Federation (IDF).
RESULTS: Among the 90 patients included in the study, the prevalence of MS as per IDF was 37.8 per cent and it was significantly associated with the body mass index (BMI). INTERPRETATION &
CONCLUSIONS: The present findings showed a higher prevalence of MS in psychiatric inpatients than that in the general population. Further studies on a larger sample need to be done before advising evaluation for the presence of MS in all psychiatric patients.

Entities:  

Mesh:

Year:  2010        PMID: 20167973

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  9 in total

1.  Association of Inflammatory and Liver Markers with Cardiometabolic Risk Factors in Patients with Depression.

Authors:  Naresh Nebhinani; Praveen Sharma; Vrinda Pareek; Navratan Suthar; Shobhan Jakhotia; Mukesh Gehlot; Purvi Purohit
Journal:  Indian J Clin Biochem       Date:  2018-02-15

2.  Assessment of insulin resistance and metabolic syndrome in drug naive patients of bipolar disorder.

Authors:  Prathama Guha; Kaushik Bhowmick; Piyanku Mazumder; Malay Ghosal; Indranil Chakraborty; Prabir Burman
Journal:  Indian J Clin Biochem       Date:  2013-01-10

3.  Prevalence of Metabolic Syndrome among Psychiatric Inpatients: A Hospital Based Study from Kashmir.

Authors:  Tajamul Hussain; Mushtaq Ahmad Margoob; Sheikh Shoib; Mahak Shafat; Rajesh Kumar Chandel
Journal:  J Clin Diagn Res       Date:  2017-06-01

4.  Metabolic syndrome in schizophrenia: Differences between antipsychotic-naïve and treated patients.

Authors:  Rakesh K Chadda; Prashanth Ramshankar; Koushik S Deb; Mamta Sood
Journal:  J Pharmacol Pharmacother       Date:  2013-07

5.  Prevalence & correlates of metabolic syndrome in alcohol & opioid dependent inpatients.

Authors:  Surendra K Mattoo; Kaustav Chakraborty; Debasish Basu; Abhishek Ghosh; K G Vijaya Kumar; Parmanand Kulhara
Journal:  Indian J Med Res       Date:  2011-09       Impact factor: 2.375

6.  Metabolic syndrome among patients receiving clozapine: A preliminary estimate.

Authors:  Sandeep Grover; Naresh Nebhinani; Subho Chakrabarti; Ajit Avasthi; Parmanand Kulhara
Journal:  Indian J Pharmacol       Date:  2011-09       Impact factor: 1.200

7.  Metabolic syndrome and central obesity in depression: A cross-sectional study.

Authors:  Anju Agarwal; Manu Agarwal; Kabir Garg; Pronob Kumar Dalal; Jitendra Kumar Trivedi; J S Srivastava
Journal:  Indian J Psychiatry       Date:  2016 Jul-Sep       Impact factor: 1.759

8.  Secondary metabolic syndrome: the frequency of factors which may underlie the parameters of metabolic syndrome.

Authors:  Aytekin Oguz; Banu Mesci; Gul Sagun; Damla Coksert Kilic; Demet Ozgil Yetkin; Arzu Akalin
Journal:  Ann Saudi Med       Date:  2013 Nov-Dec       Impact factor: 1.526

9.  Association of metabolic syndrome with schizophrenia.

Authors:  Sarita Bajaj; Anurag Varma; Anubha Srivastava; Anand Kumar Verma
Journal:  Indian J Endocrinol Metab       Date:  2013-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.